Skip to main content

Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: Primary care clinic for refugee claimants, Montreal, Canada.

OBJECTIVES: To identify factors linked to the acceptance of the tuberculin skin test (TST), and assess completion of treatment for latent tuberculosis infection (LTBI).

DESIGN: Asylum seekers consulting for a medical complaint or medical immigration examination between February and October 1999 were assessed for eligibility. Personal and clinical information was gathered prospectively by questionnaire. Hospital files were reviewed to assess completion of LTBI treatment.

RESULTS: In our study, 296 subjects (72.4% of 409 eligible) were offered TST, of whom 227 accepted (76.7%). Of these, 49 (24.9%) had a TST ≥10 mm and 24 (49%) completed 6 months of LTBI treatment. Logistic regression models showed that patients who had never had a TST (OR 3.2, 95%CI 1.34–7.6) or had no temporary exclusion criteria (OR 4.0, 95%CI 1.6–9.9) were more likely to accept TST. Perceiving tuberculosis as a severe disease (OR 0.29, 95%CI 0.09–0.91) and consulting for an immigration examination (OR 0.42, 95%CI 0.18–0.98) was associated with refusal of TST. Increasing age was found to be independently associated with a positive TST (OR 1.06, 95%CI 1.01–1.12). Variability in the proportion of positive results was found between TST readers.

CONCLUSION: This study supports the feasibility of screening refugee claimants for LTBI during medical consultation and of developing organizational links to ensure completion of LTBI treatment.

Keywords: latent tuberculosis infection; preventive treatment; refugees; screening

Document Type: Regular Paper

Affiliations: 1: Direction des systèmes de soins et services, Institut national de santé publique du Québec, Montreal, Quebec, Canada; Direction de Santé Publique de Montréal-Centre, Montreal, Quebec, Canada; and the Département de Médecine sociale et préventive, Université de Montréal, Montreal, Quebec, Canada 2: CLSC Côte-des-Neiges, Clinique Santé-Accueil, Montreal, Quebec, Canada 3: Direction de Santé Publique de Montréal-Centre, Montreal, Quebec, Canada; Département de Médecine sociale et préventive, Université de Montréal, Montreal, Quebec, Canada; and the Department of Epidemiology, Biostatstics and Occupational Health, McGill University, Montreal, Quebec, Canada

Publication date: 01 June 2004

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content